DocGo (DCGO) Competitors $1.40 +0.07 (+5.26%) Closing price 08/4/2025 04:00 PM EasternExtended Trading$1.25 -0.15 (-10.71%) As of 04:02 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock DCGO vs. PSNL, FLGT, CELC, INNV, OMDA, SBC, LFMD, AUNA, CSTL, and TALKShould you be buying DocGo stock or one of its competitors? The main competitors of DocGo include Personalis (PSNL), Fulgent Genetics (FLGT), Celcuity (CELC), InnovAge (INNV), Omada Health (OMDA), SBC Medical Group (SBC), LifeMD (LFMD), Auna (AUNA), Castle Biosciences (CSTL), and Talkspace (TALK). These companies are all part of the "healthcare" industry. DocGo vs. Its Competitors Personalis Fulgent Genetics Celcuity InnovAge Omada Health SBC Medical Group LifeMD Auna Castle Biosciences Talkspace Personalis (NASDAQ:PSNL) and DocGo (NASDAQ:DCGO) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, earnings, risk, media sentiment, institutional ownership, profitability, analyst recommendations and valuation. Which has better earnings and valuation, PSNL or DCGO? DocGo has higher revenue and earnings than Personalis. DocGo is trading at a lower price-to-earnings ratio than Personalis, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPersonalis$84.61M5.81-$81.28M-$1.29-4.32DocGo$520.50M0.27$19.99M-$0.02-70.00 Does the media favor PSNL or DCGO? In the previous week, Personalis and Personalis both had 6 articles in the media. DocGo's average media sentiment score of 0.68 beat Personalis' score of 0.02 indicating that DocGo is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Personalis 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral DocGo 2 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts prefer PSNL or DCGO? Personalis presently has a consensus target price of $7.67, indicating a potential upside of 37.64%. DocGo has a consensus target price of $3.56, indicating a potential upside of 154.29%. Given DocGo's higher probable upside, analysts plainly believe DocGo is more favorable than Personalis.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Personalis 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00DocGo 0 Sell rating(s) 3 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50 Is PSNL or DCGO more profitable? DocGo has a net margin of -0.12% compared to Personalis' net margin of -98.10%. DocGo's return on equity of 2.52% beat Personalis' return on equity.Company Net Margins Return on Equity Return on Assets Personalis-98.10% -48.78% -34.70% DocGo -0.12%2.52%1.70% Which has more volatility & risk, PSNL or DCGO? Personalis has a beta of 1.86, indicating that its stock price is 86% more volatile than the S&P 500. Comparatively, DocGo has a beta of 0.96, indicating that its stock price is 4% less volatile than the S&P 500. Do institutionals & insiders believe in PSNL or DCGO? 61.9% of Personalis shares are owned by institutional investors. Comparatively, 56.4% of DocGo shares are owned by institutional investors. 3.8% of Personalis shares are owned by company insiders. Comparatively, 2.7% of DocGo shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. SummaryDocGo beats Personalis on 8 of the 15 factors compared between the two stocks. Get DocGo News Delivered to You Automatically Sign up to receive the latest news and ratings for DCGO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DCGO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DCGO vs. The Competition Export to ExcelMetricDocGoMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$135.64M$7.13B$5.51B$9.35BDividend YieldN/A2.89%4.74%4.16%P/E Ratio-70.0066.5229.1824.41Price / Sales0.2733.67435.00101.08Price / Cash3.1525.5124.4827.20Price / Book0.458.078.485.77Net Income$19.99M$239.96M$3.24B$264.99M7 Day Performance-1.41%5.33%0.64%-0.68%1 Month Performance-11.67%1.08%7.95%7.08%1 Year Performance-54.84%27.56%30.37%23.80% DocGo Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DCGODocGo2.9239 of 5 stars$1.40+5.3%$3.56+154.3%-56.9%$135.64M$520.50M-70.004,407Upcoming EarningsPSNLPersonalis3.8277 of 5 stars$6.15-5.2%$7.67+24.7%+54.7%$573.23M$84.61M-4.77400Positive NewsFLGTFulgent Genetics4.2334 of 5 stars$18.02-1.9%$24.00+33.2%-26.7%$559.25M$283.47M-13.551,313News CoverageEarnings ReportAnalyst ForecastCELCCelcuity0.8544 of 5 stars$36.79+167.2%$39.20+6.6%+149.6%$521.42MN/A-12.1440High Trading VolumeINNVInnovAge1.4231 of 5 stars$3.75-2.3%$5.00+33.3%-41.1%$518.45M$831.68M-16.302,350Gap UpOMDAOmada HealthN/A$18.58-3.3%$23.86+28.4%N/A$494.66MN/A0.00849Positive NewsSBCSBC Medical GroupN/A$4.60-3.4%N/AN/A$493.19M$205.42M0.00N/ALFMDLifeMD1.5934 of 5 stars$10.87+1.7%$13.86+27.5%+87.4%$485.83M$212.45M-31.97230News CoverageAnalyst DowngradeGap UpAUNAAuna3.5799 of 5 stars$6.18-1.5%$10.70+73.3%-22.8%$464.06M$1.17B10.6514,842CSTLCastle Biosciences3.0006 of 5 stars$16.33+1.6%$37.00+126.6%-31.2%$463.97M$347.08M-85.95540News CoverageEarnings ReportTALKTalkspace3.7058 of 5 stars$2.56+1.6%$4.50+75.8%+28.3%$420.80M$194.36M128.06500 Related Companies and Tools Related Companies PSNL Alternatives FLGT Alternatives CELC Alternatives INNV Alternatives OMDA Alternatives SBC Alternatives LFMD Alternatives AUNA Alternatives CSTL Alternatives TALK Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DCGO) was last updated on 8/5/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredLeaked Gov’t Memo Reveals $100 Trillion DeadlineOnly Days Left to Claim Your Share of Trump's $100T Play Trump's economic blueprint is about to go live, an...Stansberry Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DocGo Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DocGo With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DCGO Stock Alerts